During the past decade, Border Medical Oncology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Border Medical Oncology" #1 sponsor was "Genentech, Inc." with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Akesobio Australia Pty Ltd" with 1 trials sponsored, "BeyondSpring Pharmaceuticals Inc." with 1 trials sponsored and "Immutep S.A.S." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Border Medical Oncology" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Border Medical Oncology" are "Advanced Cancer" (1 trials), "Advanced Solid Tumors" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Pancreatic Ductal" (1 trials) and "Esophageal Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Border Medical Oncology" in a lesser frequency.

Most popular intervention types in "Border Medical Oncology" are "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Paclitaxel" (2 trials), "Vemurafenib" (2 trials), "AK-105" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Border Medical Oncology" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Border Medical Oncology". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Border Medical Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Border Medical Oncology, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".